186 related articles for article (PubMed ID: 3566787)
41. Renal glutathione depletion and nephrotoxicity of cadmium-metallothionein in rats.
Suzuki CA; Cherian MG
Toxicol Appl Pharmacol; 1989 May; 98(3):544-52. PubMed ID: 2718180
[TBL] [Abstract][Full Text] [Related]
42. Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH.
Aebi S; Lauterburg BH
Am J Physiol; 1992 Aug; 263(2 Pt 2):R348-52. PubMed ID: 1510173
[TBL] [Abstract][Full Text] [Related]
43. Effect of buthionine sulfoximine on orthophenylphenol-induced hepato- and nephrotoxic potential in male rats.
Nakagawa Y; Tayama K
Arch Toxicol; 1988; 62(6):452-7. PubMed ID: 3250375
[TBL] [Abstract][Full Text] [Related]
44. Toxic effects of extended glutathione depletion by buthionine sulfoximine on murine mammary carcinoma cells.
Dethlefsen LA; Biaglow JE; Peck VM; Ridinger DN
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1157-60. PubMed ID: 3744934
[TBL] [Abstract][Full Text] [Related]
45. Effect of an altered glutathione content on renal ischemic injury.
Scaduto RC; Gattone VH; Grotyohann LW; Wertz J; Martin LF
Am J Physiol; 1988 Nov; 255(5 Pt 2):F911-21. PubMed ID: 3189564
[TBL] [Abstract][Full Text] [Related]
46. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels.
Ramos O; Carrizales L; Yáñez L; Mejía J; Batres L; Ortíz D; Díaz-Barriga F
Environ Health Perspect; 1995 Feb; 103 Suppl 1(Suppl 1):85-8. PubMed ID: 7621808
[TBL] [Abstract][Full Text] [Related]
47. Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum.
Pileblad E; Magnusson T; Fornstedt B
J Neurochem; 1989 Mar; 52(3):978-80. PubMed ID: 2493072
[TBL] [Abstract][Full Text] [Related]
48. Differential effect of cyanohydroxybutene on glutathione synthesis in liver and pancreas of male rats.
Davis MA; Wallig MA; Eaton D; Borroz KI; Jeffery EH
Toxicol Appl Pharmacol; 1993 Dec; 123(2):257-64. PubMed ID: 7902618
[TBL] [Abstract][Full Text] [Related]
49. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
Gallagher EP; Hasspieler BM; Di Giulio RT
Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
[TBL] [Abstract][Full Text] [Related]
50. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
Yan CC; Huxtable RJ
Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
[TBL] [Abstract][Full Text] [Related]
51. Alteration of precocene II-induced hepatotoxicity by modulation of hepatic glutathione levels.
Duddy SK; Hsia MT
Chem Biol Interact; 1989; 71(2-3):187-99. PubMed ID: 2598296
[TBL] [Abstract][Full Text] [Related]
52. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
[TBL] [Abstract][Full Text] [Related]
54. Plasma glutathione turnover in the rat: effect of fasting and buthionine sulfoximine.
Hum S; Robitaille L; Hoffer LJ
Can J Physiol Pharmacol; 1991 May; 69(5):581-7. PubMed ID: 1863907
[TBL] [Abstract][Full Text] [Related]
55. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
Bailey HH; Mulcahy RT; Tutsch KD; Arzoomanian RZ; Alberti D; Tombes MB; Wilding G; Pomplun M; Spriggs DR
J Clin Oncol; 1994 Jan; 12(1):194-205. PubMed ID: 8270977
[TBL] [Abstract][Full Text] [Related]
56. The glutathione status of rat kidney nuclei following administration of buthionine sulfoximine.
Tirmenstein MA; Reed DJ
Biochem Biophys Res Commun; 1988 Sep; 155(2):956-61. PubMed ID: 3421975
[TBL] [Abstract][Full Text] [Related]
57. Modulation by glutathione of DNA strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its aldehyde metabolites in rat hepatocytes.
Demkowicz-Dobrzanski K; Castonguay A
Carcinogenesis; 1992 Aug; 13(8):1447-54. PubMed ID: 1499096
[TBL] [Abstract][Full Text] [Related]
58. Marked reduction of rat brain glutathione following intracerebroventricular administration of the glutathione synthesis inhibitor L-buthionine sulfoximine.
Pileblad E; Magnusson T
Neurosci Lett; 1988 Dec; 95(1-3):302-6. PubMed ID: 3226616
[No Abstract] [Full Text] [Related]
59. Production of lipid hydroperoxides and depletion of reduced glutathione in liver mitochondria after acute ethanol administration to rats.
Trenti T; Sternieri E; Ceccarelli D; Gallesi D; Masini A
Toxicol Lett; 1992 Dec; 64-65 Spec No():751-5. PubMed ID: 1471231
[TBL] [Abstract][Full Text] [Related]
60. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
Manning BW; Franklin MR; Galinsky RE
Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
